AAA Mayo Clinic keeps Sensely company for series B

Mayo Clinic keeps Sensely company for series B

US-based patient engagement and monitoring platform developer Sensely secured $8m in series B funding from investors including medical research group Mayo Clinic on Tuesday.

The round was led by private equity and venture capital firm Chengwei Capital and included Stanford University’s StartX fund, life sciences-focused venture capital fund Bioveda Ventures and VC firm Fenox Venture Capital.

Sensely was incubated within telecommunications firm Orange and spun out in 2013. It has developed an artificial intelligence-based medical assistant called Molly (pictured) that interacts with patients through a mobile app, making sure they follow their prescribed care plan.

The platform collects real-time data and alerts doctors if a patient’s condition fails to improve or worsens, at which point the clinician can contact them through a video call or coordinate a specialist. Molly supports more than 20 different diseases, such as diabetes and congestive heart failure.

The capital injection will accelerate Sensely’s development and support an expansion across the US as well as the UK and other international markets.

Sensely previously received $2.2m in a 2015 series A round featuring Launchpad Digital Health, Fenox Venture Capital and TA Ventures. The company also secured $1.25m in seed funding from unnamed backers in September 2014 and an undisclosed sum from Zillionize in March 2014.

– Image courtesy of Sensely

Leave a comment

Your email address will not be published. Required fields are marked *